APO RESEARCH · REPORT
Sevoflurane
Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.
Product & engineering
Understand the product.
Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.
In this report, one unit is 250 ml Sevoflurane.
Selected research
Market Analysis & Forecast
Global Sevoflurane Market Analysis and Forecast 2026-2032
Market perspective
Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.
In this report, one unit is 250 ml Sevoflurane.
Europe is the largest Sevoflurane market with about 40% market share. Asia is follower, accounting for about 25% market share.
Read the full market overview
The key players are Abbott, Baxter, Maruishi, Jiangsu Hengrui, Lunan etc. Top 3 companies occupied about 63% market share.
This report presents an overview of global market for Sevoflurane, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Sevoflurane, also provides the consumption of main regions and countries. Of the upcoming market potential for Sevoflurane, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sevoflurane sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sevoflurane market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Sevoflurane sales, projected growth trends, production technology, application and end-user industry.
Sevoflurane Segment by Company
Abbott
Baxter
Maruishi
Jiangsu Hengrui
Lunan
Sevoflurane Segment by Type
Generic Drug
Original Drug
Sevoflurane Segment by Application
Hospitals
Other Medical Institutions
Sevoflurane Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sevoflurane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sevoflurane and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sevoflurane.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sevoflurane production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4: Sales (consumption), revenue of Sevoflurane in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 5: Detailed analysis of Sevoflurane manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sevoflurane sales, revenue, price, gross margin, and recent development, etc.
Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 11: China by type, by application, sales, and revenue for each segment.
Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 15: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Generic Drug
- Original Drug
Applications
- Hospitals
- Other Medical Institutions
Companies covered
- Abbott
- Baxter
- Maruishi
- Jiangsu Hengrui
- Lunan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Sevoflurane Market by Type
- 1.2.1 Global Sevoflurane Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Generic Drug
- 1.2.3 Original Drug
- 1.3 Sevoflurane Market by Application
- 1.3.1 Global Sevoflurane Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Other Medical Institutions
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Sevoflurane Market Dynamics
- 2.1 Sevoflurane Industry Trends
- 2.2 Sevoflurane Industry Drivers
- 2.3 Sevoflurane Industry Opportunities and Challenges
- 2.4 Sevoflurane Industry Restraints
3 Global Sevoflurane Production Overview
- 3.1 Global Sevoflurane Production Capacity (2021-2032)
- 3.2 Global Sevoflurane Production by Region: 2021 VS 2025 VS 2032
- 3.3 Global Sevoflurane Production by Region
- 3.3.1 Global Sevoflurane Production by Region (2021-2026)
- 3.3.2 Global Sevoflurane Production by Region (2027-2032)
- 3.3.3 Global Sevoflurane Production Market Share by Region (2021-2032)
- 3.4 North America
- 3.5 Europe
- 3.6 China
- 3.7 Japan
4 Global Market Growth Prospects
- 4.1 Global Sevoflurane Revenue Estimates and Forecasts (2021-2032)
- 4.2 Global Sevoflurane Revenue by Region
- 4.2.1 Global Sevoflurane Revenue by Region: 2021 VS 2025 VS 2032
- 4.2.2 Global Sevoflurane Revenue by Region (2021-2026)
- 4.2.3 Global Sevoflurane Revenue by Region (2027-2032)
- 4.2.4 Global Sevoflurane Revenue Market Share by Region (2021-2032)
- 4.3 Global Sevoflurane Sales Estimates and Forecasts 2021-2032
- 4.4 Global Sevoflurane Sales by Region
- 4.4.1 Global Sevoflurane Sales by Region: 2021 VS 2025 VS 2032
- 4.4.2 Global Sevoflurane Sales by Region (2021-2026)
- 4.4.3 Global Sevoflurane Sales by Region (2027-2032)
- 4.4.4 Global Sevoflurane Sales Market Share by Region (2021-2032)
- 4.5 North America
- 4.6 Europe
- 4.7 China
- 4.8 Asia (Excluding China)
- 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
- 5.1 Global Sevoflurane Revenue by Manufacturers
- 5.1.1 Global Sevoflurane Revenue by Manufacturers (2021-2026)
- 5.1.2 Global Sevoflurane Revenue Market Share by Manufacturers (2021-2026)
- 5.1.3 Global Sevoflurane Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 5.2 Global Sevoflurane Sales by Manufacturers
- 5.2.1 Global Sevoflurane Sales by Manufacturers (2021-2026)
- 5.2.2 Global Sevoflurane Sales Market Share by Manufacturers (2021-2026)
- 5.2.3 Global Sevoflurane Manufacturers Sales Share Top 10 and Top 5 in 2025
- 5.3 Global Sevoflurane Sales Price by Manufacturers (2021-2026)
- 5.4 Global Sevoflurane Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 5.5 Global Sevoflurane Key Manufacturers Manufacturing Sites & Headquarters
- 5.6 Global Sevoflurane Manufacturers, Product Type & Application
- 5.7 Global Sevoflurane Manufacturers Commercialization Time
- 5.8 Market Competitive Analysis
- 5.8.1 Global Sevoflurane Market CR5 and HHI
- 5.8.2 2025 Sevoflurane Tier 1, Tier 2, and Tier 3
6 Sevoflurane Market by Type
- 6.1 Global Sevoflurane Revenue by Type
- 6.1.1 Global Sevoflurane Revenue by Type (2021-2032) & (US$ Million)
- 6.1.2 Global Sevoflurane Revenue Market Share by Type (2021-2032)
- 6.2 Global Sevoflurane Sales by Type
- 6.2.1 Global Sevoflurane Sales by Type (2021-2032) & (K t)
- 6.2.2 Global Sevoflurane Sales Market Share by Type (2021-2032)
- 6.3 Global Sevoflurane Price by Type
7 Sevoflurane Market by Application
- 7.1 Global Sevoflurane Revenue by Application
- 7.1.1 Global Sevoflurane Revenue by Application (2021-2032) & (US$ Million)
- 7.1.2 Global Sevoflurane Revenue Market Share by Application (2021-2032)
- 7.2 Global Sevoflurane Sales by Application
- 7.2.1 Global Sevoflurane Sales by Application (2021-2032) & (K t)
- 7.2.2 Global Sevoflurane Sales Market Share by Application (2021-2032)
- 7.3 Global Sevoflurane Price by Application
8 Company Profiles
- 8.1 Abbott
- 8.1.1 Abbott Company Information
- 8.1.2 Abbott Business Overview
- 8.1.3 Abbott Sevoflurane Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.1.4 Abbott Sevoflurane Product Portfolio
- 8.1.5 Abbott Recent Developments
- 8.2 Baxter
- 8.2.1 Baxter Company Information
- 8.2.2 Baxter Business Overview
- 8.2.3 Baxter Sevoflurane Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.2.4 Baxter Sevoflurane Product Portfolio
- 8.2.5 Baxter Recent Developments
- 8.3 Maruishi
- 8.3.1 Maruishi Company Information
- 8.3.2 Maruishi Business Overview
- 8.3.3 Maruishi Sevoflurane Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.3.4 Maruishi Sevoflurane Product Portfolio
- 8.3.5 Maruishi Recent Developments
- 8.4 Jiangsu Hengrui
- 8.4.1 Jiangsu Hengrui Company Information
- 8.4.2 Jiangsu Hengrui Business Overview
- 8.4.3 Jiangsu Hengrui Sevoflurane Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.4.4 Jiangsu Hengrui Sevoflurane Product Portfolio
- 8.4.5 Jiangsu Hengrui Recent Developments
- 8.5 Lunan
- 8.5.1 Lunan Company Information
- 8.5.2 Lunan Business Overview
- 8.5.3 Lunan Sevoflurane Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.5.4 Lunan Sevoflurane Product Portfolio
- 8.5.5 Lunan Recent Developments
9 North America
- 9.1 North America Sevoflurane Market Size by Type
- 9.1.1 North America Sevoflurane Revenue by Type (2021-2032)
- 9.1.2 North America Sevoflurane Sales by Type (2021-2032)
- 9.1.3 North America Sevoflurane Price by Type (2021-2032)
- 9.2 North America Sevoflurane Market Size by Application
- 9.2.1 North America Sevoflurane Revenue by Application (2021-2032)
- 9.2.2 North America Sevoflurane Sales by Application (2021-2032)
- 9.2.3 North America Sevoflurane Price by Application (2021-2032)
- 9.3 North America Sevoflurane Market Size by Country
- 9.3.1 North America Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 North America Sevoflurane Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 North America Sevoflurane Price by Country (2021-2032)
- 9.3.4 United States
- 9.3.5 Canada
- 9.3.6 Mexico
10 Europe
- 10.1 Europe Sevoflurane Market Size by Type
- 10.1.1 Europe Sevoflurane Revenue by Type (2021-2032)
- 10.1.2 Europe Sevoflurane Sales by Type (2021-2032)
- 10.1.3 Europe Sevoflurane Price by Type (2021-2032)
- 10.2 Europe Sevoflurane Market Size by Application
- 10.2.1 Europe Sevoflurane Revenue by Application (2021-2032)
- 10.2.2 Europe Sevoflurane Sales by Application (2021-2032)
- 10.2.3 Europe Sevoflurane Price by Application (2021-2032)
- 10.3 Europe Sevoflurane Market Size by Country
- 10.3.1 Europe Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 10.3.2 Europe Sevoflurane Sales by Country (2021 VS 2025 VS 2032)
- 10.3.3 Europe Sevoflurane Price by Country (2021-2032)
- 10.3.4 Germany
- 10.3.5 France
- 10.3.6 U.K.
- 10.3.7 Italy
- 10.3.8 Russia
- 10.3.9 Spain
- 10.3.10 Netherlands
- 10.3.11 Switzerland
- 10.3.12 Sweden
11 China
- 11.1 China Sevoflurane Market Size by Type
- 11.1.1 China Sevoflurane Revenue by Type (2021-2032)
- 11.1.2 China Sevoflurane Sales by Type (2021-2032)
- 11.1.3 China Sevoflurane Price by Type (2021-2032)
- 11.2 China Sevoflurane Market Size by Application
- 11.2.1 China Sevoflurane Revenue by Application (2021-2032)
- 11.2.2 China Sevoflurane Sales by Application (2021-2032)
- 11.2.3 China Sevoflurane Price by Application (2021-2032)
12 Asia (Excluding China)
- 12.1 Asia Sevoflurane Market Size by Type
- 12.1.1 Asia Sevoflurane Revenue by Type (2021-2032)
- 12.1.2 Asia Sevoflurane Sales by Type (2021-2032)
- 12.1.3 Asia Sevoflurane Price by Type (2021-2032)
- 12.2 Asia Sevoflurane Market Size by Application
- 12.2.1 Asia Sevoflurane Revenue by Application (2021-2032)
- 12.2.2 Asia Sevoflurane Sales by Application (2021-2032)
- 12.2.3 Asia Sevoflurane Price by Application (2021-2032)
- 12.3 Asia Sevoflurane Market Size by Country
- 12.3.1 Asia Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 Asia Sevoflurane Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 Asia Sevoflurane Price by Country (2021-2032)
- 12.3.4 Japan
- 12.3.5 South Korea
- 12.3.6 India
- 12.3.7 Australia
- 12.3.8 Taiwan
- 12.3.9 Southeast Asia
13 South America, Middle East and Africa
- 13.1 SAMEA Sevoflurane Market Size by Type
- 13.1.1 SAMEA Sevoflurane Revenue by Type (2021-2032)
- 13.1.2 SAMEA Sevoflurane Sales by Type (2021-2032)
- 13.1.3 SAMEA Sevoflurane Price by Type (2021-2032)
- 13.2 SAMEA Sevoflurane Market Size by Application
- 13.2.1 SAMEA Sevoflurane Revenue by Application (2021-2032)
- 13.2.2 SAMEA Sevoflurane Sales by Application (2021-2032)
- 13.2.3 SAMEA Sevoflurane Price by Application (2021-2032)
- 13.3 SAMEA Sevoflurane Market Size by Country
- 13.3.1 SAMEA Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 13.3.2 SAMEA Sevoflurane Sales by Country (2021 VS 2025 VS 2032)
- 13.3.3 SAMEA Sevoflurane Price by Country (2021-2032)
- 13.3.4 Brazil
- 13.3.5 Argentina
- 13.3.6 Chile
- 13.3.7 Colombia
- 13.3.8 Peru
- 13.3.9 Saudi Arabia
- 13.3.10 Israel
- 13.3.11 UAE
- 13.3.12 Turkey
- 13.3.13 Iran
- 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
- 14.1 Sevoflurane Value Chain Analysis
- 14.1.1 Sevoflurane Key Raw Materials
- 14.1.2 Raw Materials Key Suppliers
- 14.1.3 Manufacturing Cost Structure
- 14.1.4 Sevoflurane Production Mode & Process
- 14.2 Sevoflurane Sales Channels Analysis
- 14.2.1 Direct Comparison with Distribution Share
- 14.2.2 Sevoflurane Distributors
- 14.2.3 Sevoflurane Customers
15 Concluding Insights
16 Appendix
- 16.1 Reasons for Doing This Study
- 16.2 Research Methodology
- 16.3 Research Process
- 16.4 Authors List of This Report
- 16.5 Data Source
- 16.5.1 Secondary Sources
- 16.5.2 Primary Sources
- 16.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst